ECSP982362A - QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY - Google Patents

QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY

Info

Publication number
ECSP982362A
ECSP982362A ECSP982362A ECSP982362A EC SP982362 A ECSP982362 A EC SP982362A EC SP982362 A ECSP982362 A EC SP982362A EC SP982362 A ECSP982362 A EC SP982362A
Authority
EC
Ecuador
Prior art keywords
therapy
compounds useful
quinoline
quinazoline compounds
quinazoline
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Fox David Nathan Abraham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982362 priority Critical patent/ECSP982362A/en
Publication of ECSP982362A publication Critical patent/ECSP982362A/en

Links

Abstract

Esta invención se refiere a nuevos compuestos útiles en terapia, particularmente en el tratamiento de la hiperplasia prostática benigna.This invention relates to novel compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia.

ECSP982362 1998-01-08 1998-01-08 QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY ECSP982362A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982362 ECSP982362A (en) 1998-01-08 1998-01-08 QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982362 ECSP982362A (en) 1998-01-08 1998-01-08 QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY

Publications (1)

Publication Number Publication Date
ECSP982362A true ECSP982362A (en) 1998-12-22

Family

ID=42043285

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982362 ECSP982362A (en) 1998-01-08 1998-01-08 QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY

Country Status (1)

Country Link
EC (1) ECSP982362A (en)

Similar Documents

Publication Publication Date Title
NO993396D0 (en) Quinolinic quinoline compounds useful in therapy, especially in the treatment of benign prostatic hyperplasia
DE60023982D1 (en) System for the treatment of benign prostatic hyperplasia
NO20014560L (en) Quinasolines and their therapeutic use
DE60033658D1 (en) TREATMENT OF PROSTATE CANCER WITH ANTI-ERBB2 ANTIBODIES
TR200103216T2 (en) Pyrimidinone compositions
TR199801195T2 (en) Quinoline and quinosil compounds useful in therapy.
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
DE60009888T2 (en) SUBSTITUTED 3-CYANO- [1.7], [1.5] AND [1.8] NAPHTHYRIDININHIBITORS OF TYROSINE KINASES
ATE361075T1 (en) PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF BENIGAN PROSTATE HYPERPLASIA OR FOR THE LONG-TERM PREVENTION OF ACUTE URINARY RETENTION
PT984777E (en) AILOSUBSTITUIDAL PILOTAZINES IN THE TREATMENT OF BENOSTINE PROSTATE HYPERPLASIA
ZA991315B (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
ECSP982362A (en) QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY
EA200401100A1 (en) 1α-FTOR-25-HYDROXY-16,23E-DIEN-26,27-BISHOMO-20-EPICHOLOCALTI-SPHEROL AND ITS APPLICATION FOR TREATMENT
ZA991319B (en) Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
TR200003084T2 (en) Paroxetine ascorbate
GT199700003A (en) QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY.
ATE222263T1 (en) PROSTATE-SPECIFIC ANTIGEN INHIBITORS
SI1501517T1 (en) Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention